Napier Park Global Capital (Us) LP Biogen Inc. Transaction History
Napier Park Global Capital (Us) LP
- $35 Million
- Q2 2022
A detailed history of Napier Park Global Capital (Us) LP transactions in Biogen Inc. stock. As of the latest transaction made, Napier Park Global Capital (Us) LP holds 32,500 shares of BIIB stock, worth $4.57 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
32,500Holding current value
$4.57 Million% of portfolio
0.09%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BIIB
# of Institutions
1,018Shares Held
126MCall Options Held
1.12MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.34 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.29 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.04 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.03 Billion0.06% of portfolio
-
Jpmorgan Chase & CO New York, NY5.26MShares$739 Million0.08% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $20.2B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...